MAP PHARMACEUTICALS, INC. Proceeds from Common Stock Issued
MAP PHARMACEUTICALS, INC. reported Proceeds from Common Stock Issued of $196.95 million for the 111-month period ending 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2012-11-06
- MAP PHARMACEUTICALS, INC. proceeds from issuance of common stock for the quarter ending 2012-09-30 was $56.13M.
- MAP PHARMACEUTICALS, INC. proceeds from issuance of common stock for the quarter ending 2012-06-30 was $0.00.
- MAP PHARMACEUTICALS, INC. proceeds from issuance of common stock for the quarter ending 2012-03-31 was $0.00, a 100.00% decline year-over-year.
- MAP PHARMACEUTICALS, INC. proceeds from issuance of common stock for the quarter ending 2011-12-31 was $0.00.
- MAP PHARMACEUTICALS, INC. proceeds from issuance of common stock for fiscal 2011 was $2.00K, a 100.00% decline from fiscal 2010.
- MAP PHARMACEUTICALS, INC. proceeds from issuance of common stock for fiscal 2010 was $47.03M, a 48.74% increase from fiscal 2009.
- MAP PHARMACEUTICALS, INC. proceeds from issuance of common stock for fiscal 2009 was $31.62M.
| Period end | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 96 month | Proceeds from Issuance of Common Stock 99 month | Proceeds from Issuance of Common Stock 102 month | Proceeds from Issuance of Common Stock 105 month | Proceeds from Issuance of Common Stock 108 month | Proceeds from Issuance of Common Stock 111 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012-09-30 | $56.13M derived: 10-Q 111 month − 10-Q 108 month · filed 2012-11-06 | $56.13M derived: sum of 2 quarters · filed 2012-11-06 | $56.13M 10-Q · filed 2012-11-06 | $56.13M derived: sum of 4 quarters · filed 2012-11-06 | $196.95M 10-Q · filed 2012-11-06 | ||||||
| 2012-08-31 | $55.80M 10-Q · filed 2012-11-06 | ||||||||||
| 2012-06-30 | $0.00 derived: 10-Q 108 month − 10-Q 105 month · filed 2012-07-27 | $0.00 derived: sum of 2 quarters · filed 2012-07-27 | $0.00 derived: sum of 3 quarters · filed 2012-07-27 | $0.00 derived: sum of 4 quarters · filed 2012-11-06 | $140.82M 10-Q · filed 2012-07-27 | ||||||
| 2012-03-31 | $0.00 derived: 10-Q 105 month − 10-K 102 month · filed 2012-05-08 | $0.00 derived: sum of 2 quarters · filed 2012-05-08 | $0.00 derived: sum of 3 quarters · filed 2012-11-06 | $0.00 derived: sum of 4 quarters · filed 2012-11-06 | $140.82M 10-Q · filed 2012-05-08 | ||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $0.00 derived: sum of 2 quarters · filed 2012-11-06 | $0.00 derived: sum of 3 quarters · filed 2012-11-06 | $2.00K 10-K · filed 2012-03-30 | $140.82M 10-K · filed 2012-03-30 | ||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $0.00 derived: sum of 2 quarters · filed 2012-11-06 | $2.00K 10-Q · filed 2012-11-06 | $140.82M 10-Q/A · filed 2012-03-30 | |||||||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27 | $2.00K 10-Q · filed 2012-07-27 | $140.82M 10-Q/A · filed 2012-03-30 | ||||||||
| 2011-03-31 | $2.00K 10-Q · filed 2012-05-08 | ||||||||||
| 2010-12-31 | $47.03M 10-K · filed 2012-03-30 | ||||||||||
| 2009-12-31 | $31.62M 10-K · filed 2012-03-30 |